Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
25 studies found for:    Open Studies | "Hypertriglyceridemia"
Show Display Options
Rank Status Study
1 Recruiting Hypertriglyceridaemia - Cause and Effects
Condition: Hypertriglyceridaemia
Intervention:
2 Not yet recruiting Omega-3-Acid Ethyl Esters 90 Soft Capsules for Lowering Very High Triglycerides
Condition: Hypertriglyceridemia
Interventions: Drug: Omega-3-Acid Ethyl Esters 90 Soft Capsules;   Drug: Corn Oil
3 Recruiting Carbohydrate Metabolism Disorder Frequency in Hypertriglyceridemia Induced by Bexarotene of Cutaneous T Cell Lymphoma
Conditions: Hypertriglyceridemia;   Cutaneous T Cell Lymphoma
Intervention: Other: oral glucose tolerance test (OGTT)
4 Not yet recruiting A 12-Week Study to Assess the Efficacy Safety and Tolerability of Gemcabene in Subjects With Severe Hypertriglyceridemia
Conditions: Severe Hypertriglyceridemia;   Mixed Dyslipidemia
Interventions: Drug: Gemcabene;   Drug: Placebo Oral Tablet
5 Recruiting Effect of Vascepa on Improving Coronary Atherosclerosis in People With High Triglycerides Taking Statin Therapy
Condition: Hypertriglyceridemia
Interventions: Drug: Vascepa;   Drug: placebo
6 Not yet recruiting Safety, Tolerability, PK, and Pharmacodynamics(PD) of IONIS APOCIII-LRx in Healthy Volunteers With Elevated Triglycerides
Condition: Elevated Triglycerides (TG)
Interventions: Drug: APOC-III-L-Rx;   Drug: Placebo Comparator
7 Recruiting Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of IONIS ANGPTL3-LRx in Healthy Volunteers With Elevated Triglycerides and Subjects With Familial Hypercholesterolemia
Conditions: Hypertriglyceridemia;   Familial Hypercholesterolemia
Interventions: Drug: IONIS ANGPTL3-LRx;   Drug: Placebo (0.9%NaCl, water, riboflavin)
8 Recruiting A PK and PD Study of Two Formulations of Omega-3 One Gram Capsules
Condition: Hypertriglyceridemia
Interventions: Drug: Drug Omega 3;   Drug: Drug Omega-3 Comparator
9 Recruiting Maternal Hypertriglyceridaemia Study
Condition: Metabolic Syndrome X
Intervention: Procedure: Blood sampling
10 Recruiting Effects of DPP-4 Inhibition on Triglycerides
Conditions: Type 2 Diabetes;   Hypertriglyceridemia
Intervention: Drug: Saxagliptin
11 Recruiting Outcomes Study to Assess STatin Residual Risk Reduction With EpaNova in HiGh CV Risk PatienTs With Hypertriglyceridemia
Condition: Eligible Men or Women Considered High Risk for Atherosclerotic Cardiovascular Disease (CVD)
Interventions: Drug: Epanova® (omega-3 carboxylic acids);   Drug: corn oil control
12 Recruiting Open-Label Study To Evaluate Efficacy, Safety, Tolerability & PK of MN-001 on HDL & Triglyceride in NASH & NAFLD Subjects
Conditions: Non-alcoholic Steatohepatitis;   Hypertriglyceridemia;   Non-alcoholic Fatty Liver Disease
Intervention: Drug: MN-001
13 Recruiting Orlistat for the Treatment of Type I Hyperlipoproteinemia
Conditions: Hyperlipoproteinemia Type I;   Hypertriglyceridemia
Intervention: Drug: Orlistat
14 Recruiting Effect of Valedia on Glucose and Lipid Homeostasis on Subjects With Prediabetes
Conditions: Prediabetes;   Type 2 Diabetes;   Hypertriglyceridemia;   Obesity;   Disease;   Insulin Resistance
Interventions: Dietary Supplement: Valedia;   Dietary Supplement: Placebo
15 Recruiting Genetic Effect on Omega 3 Fatty Acids for the Treatment of Fatty Liver Disease
Conditions: Non Alcoholic Fatty Liver Disease;   Steatohepatitis;   Hypertriglyceridemia;   Alanine Aminotransferase, Plasma Level of, Quantitative Trait Locus 1
Intervention: Other: Omega diet
16 Recruiting Feasibility and Acceptability of a Beverage Intervention for Hispanic Adults
Conditions: Obesity;   Hypercholesterolemia;   Hyperglycemia;   Hypertriglyceridemia
Interventions: Other: Mediterranean Lemonade;   Other: Green Tea;   Other: Flavored Water
17 Recruiting Plasma Exchange vs Conservative Management in Non-severe Acute Hypertriglyceridemic Pancreatitis
Condition: Acute Pancreatitis
Interventions: Procedure: plasma exchange;   Drug: conservative treatment
18 Recruiting Phase 2 Study of Orlistat and SLx-4090 for the Treatment of Type 1 Hyperlipoproteinemia
Condition: Type 1 Hyperlipoproteinemia
Interventions: Drug: SLx-4090 placebo;   Drug: Orlistat Placebo;   Drug: Orlistat;   Drug: Slx-4090
19 Recruiting Efficacy, Safety and Tolerability of ISIS 304801 in People With Partial Lipodystrophy With an Open-Label Extension
Condition: Lipodystrophy
Interventions: Drug: ISIS 304801;   Drug: Placebo
20 Recruiting Genes Involved in Lipid Disorders
Condition: Dyslipidemia
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-25) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.